Evidence map›Paper›PMID 30984292›Full record

ArticleGut pathogens2019

NMR metabolomics reveals effects of

Christopher N Miller, Charalampos G Panagos, William R T Mosedale, Martin Kváč, Mark J Howard, Anastasios D Tsaousis

Open access · goldAbstract read
In one paragraph

Article in Gut pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Gut pathogens · 2023
    Article
  2. Article
  3. Article
  4. Comparative metabolic profiling byParasitology research · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Christopher N Miller1Laboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK.
Charalampos G Panagos2Biomolecular NMR Facility, School of Biosciences, University of Kent, Canterbury, UK.
William R T Mosedale1Laboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK.
Martin Kváč3Institute of Parasitology, Biology Centre CAS, Ceske Budejovice, Czech Republic.
Mark J Howard2Biomolecular NMR Facility, School of Biosciences, University of Kent, Canterbury, UK.
Anastasios D Tsaousis1Laboratory of Molecular & Evolutionary Parasitology, RAPID Group, School of Biosciences, University of Kent, Canterbury, UK.ORCID 0000-0002-5424-1905
University of Kent · GBUniversity of Georgia · USUniversity of Leeds · GBUniversity of South Bohemia in České Budějovice · CZ

Funding

Biotechnology and Biological Sciences Research Council BB/M009971/1Wellcome Trust
6 · The paper itself

Abstract

background

resultsUsing a

conclusionThis approach will spearhead our understanding of the

Indexed as

COLO-680NCryptosporidiosisMetabolomicsNMRTaurine

Identifiers

PMID30984292
PMCPMC6446323
OpenAlexW2944403676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.